This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Neophore Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Paul Winship
Introduction
Paul Winship is a notable inventor based in Saffron Walden, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on targeting specific proteins involved in the DNA Mismatch Repair process, which is crucial for maintaining genomic stability.
Latest Patents
One of Paul Winship's key patents is titled "Inhibitors of MLH1 and/or PMS2 for cancer treatment." This invention relates to compounds of Formula (I) that specifically target the MLH1 and/or PMS2 proteins. These proteins play a vital role in the DNA Mismatch Repair (MMR) process, and the compounds developed by Winship aim to enhance cancer treatment efficacy.
Career Highlights
Throughout his career, Paul Winship has demonstrated a strong commitment to advancing medical science. His work at Neophore Limited has positioned him as a leader in the development of innovative cancer therapies. With a focus on practical applications of his research, he has contributed to the understanding of how to effectively combat cancer at the molecular level.
Collaborations
Paul Winship has collaborated with esteemed colleagues such as Jon Roffey and Martin Drysdale. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, ultimately leading to groundbreaking advancements in cancer treatment.
Conclusion
In summary, Paul Winship's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his importance in the field of medical research. His work continues to inspire advancements that may significantly impact cancer therapies in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile